YoVDO

Cell-free DNA Genomic and Epigenomic Analysis to Predict Survival in mCRPC Patients

Offered By: Cancer Genomics Consortium via YouTube

Tags

Genomics Courses Epigenomics Courses Cancer Genomics Courses Liquid Biopsies Courses Precision Oncology Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore a conference talk from the Cancer Genomics Consortium's 2023 Annual Meeting focusing on cell-free DNA analysis in metastatic castration-resistant prostate cancer (mCRPC) patients. Delve into how genomic and epigenomic analysis of cell-free DNA can be used to predict survival outcomes in mCRPC patients undergoing AR-directed therapy. Learn about the latest advancements in clinical cancer genomics and their potential impact on patient diagnosis and treatment. Gain insights from speaker Pradeep Chauhan on this cutting-edge research in the field of cancer genomics. Understand the role of organizations like the Cancer Genomics Consortium in promoting best practices and education in clinical cancer genomic testing.

Syllabus

Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients


Taught by

Cancer Genomics Consortium

Related Courses

Experimental Genome Science
University of Pennsylvania via Coursera Genes and the Human Condition (From Behavior to Biotechnology)
University of Maryland, College Park via Coursera Introduction to Biology - The Secret of Life
Massachusetts Institute of Technology via edX Drug Discovery
University of California, San Diego via Coursera Human Evolution: Past and Future
University of Wisconsin–Madison via Coursera